SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines is at the center of investor focus as excitement builds around the Artemis II mission and broader optimism for the expanding lunar economy. While some community members remain wary of volatility and potential share offerings, many are actively trading the stock based on its role in critical upcoming space infrastructure projects.

Galaxy Digital, Inc. engages in digital assets and data center infrastructure, delivering solutions that accelerate progress in finance and artificial intelligence. It operates through the following segments: Digital Assets, Data Centers, and Treasury and Corporate. The digital assets segment offers institutional access to trading, advisory, asset management, staking, self-custody, and tokenization technology. The Data Centers segment competes with a range of infrastructure providers that are building or repurposing facilities to support the rapidly growing demand for AI and compute-intensive workloads. The Treasury and Corporate segment includes the company’s proprietary trading and mining activities, as well as the company’s principal investments and related gains and losses. The company was founded by Michael Novogratz in 2018 and is headquartered in New York, NY.

Galaxy Digital Inc. - Ordinary Shares - Class A

Galaxy Digital is facing intense scrutiny and negative sentiment from retail investors, driven by a perceived lack of communication from leadership regarding the Helios data center project and disappointment over the company's performance compared to sector peers. The community is actively debating the stock's future, with many expressing frustration over the recent delisting from the TSX, stagnant price action, and a lack of clear catalysts to break the current trading range.

VisionWave Holdings, Inc. engages in the forefront of revolutionizing defense capabilities by integrating advanced artificial intelligence (AI) and autonomous solutions across air, ground, and sea domains. The company was founded on March 20, 2024 and is headquartered in Wilmington, DE.

VisionWave Holdings Inc.

VisionWave Holdings, Inc.

VisionWave Holdings is trending as investors bet on a potential short squeeze, citing its low float and high institutional ownership reminiscent of previous high-volatility runners. The community is actively discussing recent patent news and corporate updates while speculating on the impact of potential future government defense contracts.

Solana is a high-performance Layer 1 blockchain designed for mass adoption by providing a fast, secure, and low-cost environment for decentralized applications. It distinguishes itself by scaling globally without the use of complex sharding or multiple layers, instead maintaining a single, unified ledger to avoid liquidity fragmentation. This architecture allows it to process thousands of transactions per second with sub-second finality, often at a cost of less than a penny per transaction.  The network operates on a unique hybrid model that combines Proof of Stake with an innovation called Proof of History, which functions as a decentralized clock to timestamp transactions. This system reduces the need for constant node communication, allowing the Sealevel engine to run non-conflicting smart contracts in parallel across multiple CPU cores. Further efficiency is gained through the Gulf Stream protocol, which reduces confirmation times by forwarding transactions to validators before the current block is finished.  Founded in 2017 by Anatoly Yakovenko, Solana is now supported by the Switzerland-based Solana Foundation and significant institutional investors like Andreessen Horowitz and Polychain Capital. The platform’s native token, SOL, serves as the primary currency for paying transaction fees, participating in network governance, and securing the system through staking.   Solana has also seen significant institutional adoption ranging from spot Solana ETFs to major partnerships including Visa's 2025 launch of USDC settlement on the network and the tokenization of public equity by firms like Galaxy Digital.

Solana

The Solana community is actively weighing in on a mix of developer-driven innovation, meme coin activity, and broader macroeconomic factors like stablecoin regulatory developments. While some participants are closely monitoring price consolidation and institutional sentiment, others remain focused on the ecosystem's resilience and long-term utility.

Mezo is the onchain Bitcoin banking platform owned by its users. Users can access self-service Bitcoin finance without interacting with loan officers, undergoing credit checks, or observing operational hours. It’s just you, your Bitcoin, and permissionless access to financial services 24/7.  Traditional banks profit from your deposits while charging you for access to your own money. Two-sided lending markets trap you with 8-9% variable rates that can spike unpredictably, especially in decentralized financial systems. Both systems put middlemen between you and your wealth.  Mezo eliminates them all, giving you the power to manage your finances intelligently on your own terms.  Deposit Bitcoin as collateral, mint MUSD (a dollar-pegged stablecoin), and use it however you need. Your Bitcoin stays yours while MUSD provides you with instant liquidity. Fixed rates start as low as 1% and stay fixed for the entire life of the loan.  This is self-service banking with complete autonomy. Unlike any traditional banking experience, there are no minimum payments, set repayment schedules, or penalties for early repayment. Close your position tomorrow or keep it open for years.  It’s your Bitcoin and your decision on what to do with it.

MEZO

Mezo is drawing significant investor interest following its listing on Coinbase as a Bitcoin-native economic layer designed to expand utility through staking and governance. Community members are actively debating the token's long-term potential compared to past Bitcoin-based projects while navigating current trading availability across exchange platforms.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

XRP is trending as investors debate the impact of the pending U.S. Clarity Act on institutional adoption, with the community split between those accumulating in anticipation of regulatory milestones and others frustrated by ongoing price stagnation and token unlock schedules. Discussion remains heavily focused on whether Ripple's evolving utility and payment infrastructure will ultimately drive long-term value despite current market volatility.

Penguin Solutions, Inc. engages in designing, building, and managing enterprise solutions. It operates through the following segments: Advanced Computing, Integrated Memory, and Optimized LED. The Advanced Computing segment offers platform solutions and services for artificial intelligence, high-performance computing, machine learning, advanced modeling, and the internet of things. The Integrated Memory refers to integrated memory solutions through the design and development. The Optimized LED segment comprises a broad portfolio of application-optimized LEDs. The company was founded in 1988 and is headquartered in Fremont, CA.

Penguin Solutions Inc.

Penguin Solutions is currently seeing heightened investor interest driven by strong earnings results, improved full-year guidance, and a strategic AI infrastructure partnership with SK Telecom. The community is actively debating the stock's long-term potential as an AI-play, with many focusing on its role in high-performance computing pipelines and debating its valuation relative to broader industry growth.

Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of psychiatric drugs. Its pipeline is composed of five clinical-stage assets which initially target depressive disorder and schizophrenia population. The company was founded by Amit Etkin, Dan Segal, and Wei Wu on March 25, 2019 and is headquartered in Mountain View, CA.

Alto Neuroscience Inc.

Alto Neuroscience is seeing significant market activity and intense community discussion following the FDA's granting of Fast Track designation to ALTO-101 for the treatment of cognitive impairment associated with schizophrenia. Investors are closely monitoring upcoming clinical trial readouts while debating the company's long-term potential, with many highlighting its strong cash runway and precision psychiatry pipeline as key drivers for long-term growth.

Nucor Corp. engages in the manufacture of steel products, and ferrous and non-ferrous materials. It operates through the following segments: Steel Mills, Steel Products, and Raw Materials. The Steel Mills segment consists of producing sheet, plate, structural, and bar steel. The Steel Products segment includes steel joists and joist girders, deck, fabricated concrete reinforcing, cold finished, fasteners, metal building systems, grating, tubular, piling products businesses, and wire mesh. The Raw Materials segment consists of direct reduced iron, and ferrous and nonferrous metals. The company was founded by Ransom E. Olds in 1905 and is headquartered in Charlotte, NC.

Nucor Corp.

Nucor is trending as investors react to reports that the Trump administration is finalizing a plan to impose 25% tariffs on all steel and aluminum imports. The community is actively discussing the potential for this policy to boost domestic demand and provide a long-term growth catalyst for U.S. producers, with many traders closely monitoring the impact on industrial pricing power.

Tema ETF Trust - Tema Space Innovators ETF

The newly launched Tema Space Innovators ETF is gaining significant traction among retail traders due to its direct exposure to SpaceX ahead of an anticipated public listing. The community is actively debating the ETF's low liquidity and AUM structure, with some participants viewing it as a high-potential momentum play while others express skepticism regarding its underlying holdings.

statis crypto Watchlist

Bitcoin

Ethereum

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Range Financial Group LLC Acquires Shares of 426,095 Ironwood Pharmaceuticals, Inc. $IRWD

Range Financial Group LLC bought a new position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 426,095 shares of the biotechnology company's st...

Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Up 5.4%  - Still a Buy?

Ironwood Pharmaceuticals (NASDAQ:IRWD) Trading 5.4% Higher - Time to Buy...

IRWD Stock Down 14% in a Month: Time to Buy, Sell or Hold the Stock?

Ironwood slides 14% in a month on weak Linzess Q4 sales, but strong demand, partnerships, and an upbeat 2026 outlook raise investor optimism.

Why Is Ironwood (IRWD) Down 13.9% Since Last Earnings Report?

Ironwood (IRWD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Given Average Recommendation of "Hold" by Brokerages

Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Get Free Report) have been given an average recommendation of "Hold" by the eight brokerages that are currently covering the firm, Marketbeat...

Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Up 9% - Time to Buy?

Ironwood Pharmaceuticals (NASDAQ:IRWD) Trading 9% Higher - Should You Buy...

Alexander Denner Sells 6,730,800 Shares of Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Get Free Report) Director Alexander Denner sold 6,730,800 shares of the business's stock in a transaction on Tuesday, March 17th. The shares were sold at...

Insider Selling: Ironwood Pharmaceuticals (NASDAQ:IRWD) Director Sells 6,730,800 Shares of Stock

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Get Free Report) Director Alexander Denner sold 6,730,800 shares of the stock in a transaction that occurred on Tuesday, March 17th. The shares were sold...

Ironwood Pharmaceuticals (NASDAQ:IRWD) Sees Strong Trading Volume - Should You Buy?

Ironwood Pharmaceuticals (NASDAQ:IRWD) Sees Large Volume Increase - Should You Buy...

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Short Interest Up 15.8% in February

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Get Free Report) saw a significant growth in short interest in February. As of February 27th, there was short interest totaling 12,917,285 shares, a...

Ironwood Pharmaceuticals, Inc. is a healthcare company, which engages in the development and commercialization of Gastrointestinal (GI) products. It operates through the Human Therapeutics segment. The company was founded on January 5, 1998 and is headquartered in Boston, MA.

Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A

Thematic ETFs

Prediction Markets

OpenClaw & Agentic-Directed Trading

Tokenization

Recognizing the tool or mechanism that redefined how we trade. From prediction markets to next-gen tech, this award honors the innovation that pushed the boundaries of access and efficiency in modern finance.

Current Price	$3.90
Prev Close	$3.51
Open	$3.59
Dividend Yield	0.00%
50-Day Moving Average	$4.04
Beta	0.76
Avg. Volume	3.5M
PE Ratio	29.13

52-Week High	$5.78
52-Week Low	$0.5271
Market Capitalization	$572.33M
EPS (Annual)	$0.1474
Price to Book	-2.19
Revenue Per Employee	$2.96M

IRWD
Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest IRWD News

IRWDIronwood Pharmaceuticals Inc - Ordinary Shares - Class A